Vaginal pessary Market - Size, Share, Industry Trends, and Forecasts (2025 - 2034)

By Product Type :

The product type segment is categorized into vaginal ring, gehrung, cube, gellhorn, and others. In 2024, the vaginal ring segment accounted for the highest market share in the vaginal pessary market. Vaginal rings are a circle-shaped device and are widely recommended as the first choice by pessary doctors. The primary benefit associated with vaginal rings includes easy insertion and removal. In addition, the patients have intercourse with a ring pessary in place. Thus, due to the above benefits, vaginal rings are utilized for the treatment of urinary incontinence. For instance, according to the recent statistics published by the National Library of Medicine, in October 2020, approximately 43–349 million women in China experienced urinary incontinence (UI). Hence, the increasing prevalence of urinary incontinence is boosting the demand for vaginal rings to minimize irritation, which, in turn, is favoring segment growth.

However, the gehrung segment is projected to be the fastest-growing segment during the forecast period. This is due to the increasing new developments associated with gehrung at the global level, which is spurring segmental growth.

By Indication :

The indication segment is categorized into pelvic organ prolapse, urinary incontinence, and others. In 2024, the urinary incontinence segment accounted for the highest market share in the vaginal pessary market and is projected to be the fastest-growing segment during the forecast period. The urinary pessary is ideal for the treatment of urinary incontinence to minimize or eradicate stress incontinence to support the urethra. Additionally, the utilization of urinary pessary is an economical treatment for urinary incontinence as compared with surgeries. The increasing prevalence of urinary tract infections, constipation, and vaginal infection or irritation is accelerating the prevalence of urinary incontinence. For instance, according to the recent data published by the National Center for Biotechnology Information, in 2021, the prevalence of urinary incontinence in women was highest in Egypt was 80%, followed by America at 59%, the Middle East at 52%, Africa at 45.3%, Australia at 38%, and Europe at 37%. Thus, the rising cases of urinary incontinence are favoring the demand for urinary pessary to reduce stress incontinence. This, in turn, is driving the market growth.

By End-User :

The end user segment is categorized into hospitals, ambulatory surgical centers, clinics, and others. In 2024, the hospitals segment accounted for the highest market share of 35.87% in the overall vaginal pessary market. The vaginal pessary is efficient to help a woman avoid pelvic surgery. Additionally, the vaginal pessary is used as a vessel for slower administration of medication. The patients find they can consistently use a pessary for two years or more without requiring surgery for their condition. Thus, the vaginal pessary is frequently deployed in hospitals. For instance, in India hospitals such as Medanta, Fortis Escorts Heart Institute, Nanavati Super Speciality Hospital., Kokilaben Dhirubhai Ambani Hospital, Sir HN Reliance Foundation Hospital & Research Centre, and others are some of the leading hospitals providing treatment of urinary incontinence and pelvic organ prolapse. These hospitals have formed strategic collaborations with vaginal pessary product manufacturers to ensure a seamless supply of products. Therefore, the rising utilization of vaginal pessary in hospitals to ensure reduction in symptoms is proliferating the market growth.

However, the clinics segment is expected to be the fastest-growing segment during the forecast period. This growth is attributed to factors such as increasing investment in new clinics, increasing government initiatives, and others.

Vaginal Pessary Market Regional Analysis:

The regional segment includes North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

North America is estimated to reach over USD 1132.24 Million by 2034 from a value of USD 424.8 Million in 2025 and is projected to grow by USD 468.55 Million in 2026. In North America, the U.S. largest market share, with 33%. This is due to the increasing deployment of vaginal pessary products in hospitals, clinics, and others in the North American region. For instance, hospitals in the North American regions such as Hartford Hospital in the United States, Brigham and Women's Hospital in the United States, Mount Sinai Hospital in Canada, and others are providing services for the treatment of urinary incontinence and pelvic organ prolapse. These hospitals employ vaginal pessary products. Thus, the increasing adoption of vaginal pessary products in hospitals across the North American region is favoring market growth.

Furthermore, Asia Pacific is expected to witness significant growth over the forecast period, growing at a CAGR of 8.9% during 2025-2034. Key trends such as the presence of key players in the Asia Pacific region, the development of new hospitals, and others are boosting market growth in the European region.